New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
OSI Pharmaceuticals (OSIP)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2009
30-JUN
2009
30-SEP
2009
31-DEC
2009
31-MAR
2010
Total Revenue
93.7M
99.1M
111M
124M
107M
Gross Profit
91.3M
106M
117M
128M
111M
Research & Development
35.4M
37.1M
38.5M
40.7M
42.0M
SG&A
24.2M
25.2M
24.7M
28.9M
39.7M
Amortization & Deprec
228K
9.94M
7.85M
7.07M
7.29M
Other Expenses
-2.44M
-2.19M
4.29M
2.23M
2.89M
Total Operating Expenses
57.4M
70.1M
75.4M
78.9M
91.9M
Operating Income
31.6M
33.8M
40.2M
47.0M
18.9M
Other Income
-384K
-2.34M
-184K
2.47M
-5.74M
EBIT
33.4M
33.5M
41.7M
51.8M
13.2M
Minority Interest
0
0
0
0
0
Interest Expense
6.39M
6.39M
6.53M
7.77M
5.29M
Income Before Taxes
27.1M
27.1M
35.1M
44.0M
7.91M
Income Taxes
10.6M
10.6M
17.3M
18.9M
3.17M
Net Income from Continuing Ops
16.5M
16.5M
17.9M
25.1M
4.74M
Income - Discontinued Ops
-104K
23.0K
-298K
315K
107K
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
16.4M
16.5M
17.6M
25.4M
4.85M
Preferred Dividends
0
0
0
0
0
Net Income to Common
16.4M
16.5M
17.6M
25.4M
4.85M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour